These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7640170)

  • 1. Lack of metabolic racemisation of ropivacaine, determined by liquid chromatography using a chiral AGP column.
    Arvidsson T; Bruce HF; Halldin MM
    Chirality; 1995; 7(4):272-7. PubMed ID: 7640170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatographic bioanalytical determination of ropivacaine, bupivacaine and major metabolites.
    Arvidsson T; Askemark Y; Halldin MM
    Biomed Chromatogr; 1999 Jun; 13(4):286-92. PubMed ID: 10416062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic determination of ropivacaine, 3-hydroxy-ropivacaine, 4-hydroxy-ropivacaine and 2',6'-pipecoloxylidide in plasma.
    Reif S; Le Corre P; Dollo G; Chevanne F; Le Verge R
    J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):239-44. PubMed ID: 9869387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereostructure-based differences in the interactions of cardiotoxic local anesthetics with cholesterol-containing biomimetic membranes.
    Tsuchiya H; Ueno T; Mizogami M
    Bioorg Med Chem; 2011 Jun; 19(11):3410-5. PubMed ID: 21550810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
    Ekström G; Gunnarsson UB
    Drug Metab Dispos; 1996 Sep; 24(9):955-61. PubMed ID: 8886604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ropivacaine: a pharmacological review.
    Hansen TG
    Expert Rev Neurother; 2004 Sep; 4(5):781-91. PubMed ID: 15853505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and excretion of ropivacaine in humans.
    Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
    Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine.
    Berggren S; Lennernäs P; Ekelund M; Weström B; Hoogstraate J; Lennernäs H
    J Pharm Pharmacol; 2003 Jul; 55(7):963-72. PubMed ID: 12906753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative motor-blocking effects of bupivacaine and ropivacaine, a new amino amide local anesthetic, in the rat and dog.
    Feldman HS; Covino BG
    Anesth Analg; 1988 Nov; 67(11):1047-52. PubMed ID: 3189893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane effects of ropivacaine compared with those of bupivacaine and mepivacaine.
    Mizogami M; Tsuchiya H; Harada J
    Fundam Clin Pharmacol; 2002 Aug; 16(4):325-30. PubMed ID: 12570022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of free concentration of ropivacaine and bupivacaine in blood plasma by ultrafiltration and coupled-column liquid chromatography.
    Arvidsson T; Eklund E
    J Chromatogr B Biomed Appl; 1995 Jun; 668(1):91-8. PubMed ID: 7550986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic analysis of ropivacaine and its metabolite 2',6'-pipecoloxylidide from pooled data in neonates, infants, and children.
    Aarons L; Sadler B; Pitsiu M; Sjövall J; Henriksson J; Molnár V
    Br J Anaesth; 2011 Sep; 107(3):409-24. PubMed ID: 21693469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of three local anesthetic drugs from the pipecoloxylidide group in human serum by high-performance liquid chromatography.
    Tanaka E; Nakamura T; Inomata S; Honda K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):213-6. PubMed ID: 16530026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on sulfation of synthesized metabolites from the local anesthetics ropivacaine and lidocaine using human cloned sulfotransferases.
    Falany CN; Falany JL; Wang J; Hedström J; von Euler Chelpin H; Swedmark S
    Drug Metab Dispos; 1999 Sep; 27(9):1057-63. PubMed ID: 10460806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative course of plasma protein binding of lignocaine, ropivacaine and bupivacaine in sheep.
    Rutten AJ; Mather LE; Plummer JL; Henning EC
    J Pharm Pharmacol; 1992 Apr; 44(4):355-8. PubMed ID: 1355550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chiral capillary electrophoresis method for ropivacaine hydrochloride in pharmaceutical formulations: validation and comparison with chiral liquid chromatography.
    Sänger-van de Griend CE; Wahlström H; Gröningsson K; Widahl-Näsman M
    J Pharm Biomed Anal; 1997 May; 15(8):1051-61. PubMed ID: 9215957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of premedication medicines on the formation of the CYP3A4-dependent metabolite of ropivacaine, 2', 6'-Pipecoloxylidide, on human liver microsomes in vitro.
    Tanaka E; Nakamura T; Inomata S; Honda K
    Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):181-3. PubMed ID: 16445592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ciprofloxacin on the pharmacokinetics of ropivacaine.
    Jokinen MJ; Olkkola KT; Ahonen J; Neuvonen PJ
    Eur J Clin Pharmacol; 2003 Feb; 58(10):653-7. PubMed ID: 12610740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ropivacaine in patients with chronic renal failure.
    Pere PJ; Ekstrand A; Salonen M; Honkanen E; Sjövall J; Henriksson J; Rosenberg PH
    Br J Anaesth; 2011 Apr; 106(4):512-21. PubMed ID: 21307007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaine.
    Leone S; Di Cianni S; Casati A; Fanelli G
    Acta Biomed; 2008 Aug; 79(2):92-105. PubMed ID: 18788503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.